UNITY Biotechnology, a company focused on developing drugs to treat age-related diseases, announced the grant of stock-based compensation to its new Chief Strategy Officer. The award, approved by the Compensation Committee of the Board of Directors, includes options to purchase 100,000 shares of UNITY common stock and 15,000 restricted stock units. The grant of a total of 115,000 shares was made under the UNITY 2020 Employment Attraction Incentive Plan, established to provide incentives to newly hired employees pursuant to Nasdaq Stock Market Rule 5635(c)(4). The award, which will become effective on July 22, 2024, will provide a significant incentive for new executives to join UNITY.
UNITY Biotechnology, based on the report of Special Envoy Maratti, will report to him as Chief Strategy Officer. The pre-approved Committee for the Compensation of the Amendments includes an option for 100,000 units of UNITY and 15,000 units of Reserve. This concession, for a total of 115.000 units, will have an effect in the Industrial Occupation of UNITY 2020, and will provide incentives and new support in accordance with the Nasdaq Stock Market Regulation 5635(c)(4). It will work energetically until 22/2024 to drive new initiatives in the pursuit of unity.
UNITY Biotechnology, as the Chief Strategic Officer, builds the best relationships. The approval of the Supreme Court, the Congressional Directives Committee includes 100,000 UNITY powers and 15,000 coordination powers, authorizing a total of 115,000 actions and establishing proportional incentives for Los Empreados Recipien Contratados Segun La Regla 5635(c)(4) del Mercado de Valores, based on the employment promotion plan of the trade union UNITY 2020. Dac. On July 22, 2024, we will prepare incentive materials to launch new initiatives and unite.
UNITY Biotechnology is proceeding with development using the latest technology. It’s a good idea. 100,000 100,000 15,000 15,000 It’s okay. UNITY 2020 UNITY 2020 UNITY 2020 UNITY 2020 UNITY 2020 로, 이 Nasdaq gets 5635(c)(4), gets 5635(c)(4). It’s okay. 2024 7 years 22 years 22 years 22 years Next.
UNITY Biotechnology is an entrepreneur that helps develop new diseases and aims to compensate for its actions as the person responsible for new strategies. The compensation is provided by the Compensation Committee of the Administration, which covers 100,000 UNITY action orders and 15,000 Restraint Unit action orders. As a result, a total of 115,000 actions have been implemented in line with the UNITY 2020 Employment Plan, which provides for the creation of new employee incentives under the umbrella of the 5635(c)(4) Marché Bourse-Siéne NASDAQ. La récompense est entrée en vigueur le 22 juillet 2024, servant de motérielle pour que le nouveau dirigeant rejoigne UNITY.
At UNITY Biotechnology, as Chief Strategy Officer, he serves as the Chief Strategy Officer and the subject of treatment. The transaction, which is based on the proposed acquisition of the Vorstandsgenehmigt, includes options for over 100,000 transactions from UNITY and 15,000 restricted stock units. This transaction, which includes over 115,000 transactions, includes the UNITY 2020 Job Promotion Incentive Plan, which was acquired by the Nasdaq Securities Co., Ltd. 5635(c)(4) as a wholly owned subsidiary of Nasdaq Securities Co., Ltd. Die Auszeichnung trat am 22. Juli 2024 in Kraft und diente als wesentlicher Anreiz für den neuen Geschäftsführer, zu UNITY zu stoßen.
positive
Appointing a new Chief Strategy Officer who may bring new strategic insights; Implementing employee incentive plans to attract top talent.
Negative
Potential Dilution of Existing Shareholders from Issuance of New Stock Options and RSUs July 24, 2024 – 8:00 A.M.
SOUTH SAN FRANCISCO, Calif., July 24, 2024 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX]UNITY, a biotechnology company developing therapeutics to slow, halt or reverse the progression of aging-related diseases, today announced that the Compensation Committee of its Board of Directors (the “Board”) has granted stock-based awards effective July 22, 2024 covering an aggregate of 115,000 shares of UNITY common stock to its new employee, its Chief Strategy Officer, including options to purchase an aggregate of 100,000 shares of UNITY common stock and 15,000 restricted stock units of UNITY common stock. The stock-based awards were granted pursuant to the UNITY 2020 Employment Attractiveness Incentive Plan, as amended, which was approved by the Board of Directors in March 2020 for the purpose of providing grants to new employees as a material inducement to commence employment with UNITY, pursuant to Nasdaq Stock Market Rule 5635(c)(4).
About UNITY
UNITY is developing a new class of therapeutics to slow, stop or reverse the progression of age-related diseases. UNITY is currently focused on developing medicines to selectively remove or modulate senescent cells, thereby providing breakthrough treatments for age-related eye and neurological diseases. For more information, visit www.unitybiotechnology.com or follow us on X and LinkedIn.
Media Contact
Inizio Evoke Communications
Katherine Smith
Katherine.Smith@inizioevoke.com
Investor Contacts
LifeSciAdvisors LLC
Joyce Allaire
jallaire@lifesciadvisors.com
FAQ
What kind of stock-based compensation did UNITY Biotechnology (UBX) grant to its new chief strategy officer?
UNITY Biotechnology has granted its new chief strategy officer an option, effective July 22, 2024, to purchase 100,000 shares of UNITY common stock and 15,000 restricted stock units, for a total of 115,000 shares.
Under what plan was the stock-based compensation granted by UNITY Biotechnology (UBX)?
The stock awards were granted under the UNITY 2020 Employment Attraction Incentive Plan, which was approved by the Board of Directors in March 2020 to provide incentives to newly hired employees.
What is UNITY Biotechnology’s (UBX) purpose in granting stock compensation to its new chief strategy officer?
The stock-based compensation will serve as a material incentive for the new Chief Strategy Officer to accept employment with UNITY Biotechnology, pursuant to Nasdaq Stock Market Rule 5635(c)(4).
When did UNITY Biotechnology (UBX) grant stock compensation to its new chief strategy officer?
UNITY Biotechnology has granted a stock-based award to its new chief strategy officer effective July 22, 2024.
